Last update:

Oncology & Cancer news

Oncology & Cancer

Epigenetic test could help predict efficacy of immunotherapy in multiple myeloma

Multiple myeloma is a type of blood cancer that appears mainly after the age of 60. Its incidence, therefore, increases with the aging of the population. In this pathology, the bone marrow, the porous structure within the ...

Oncology & Cancer

New immunotherapy shows complete responses in mantle cell lymphoma

Patients with a rare blood cancer that has relapsed or become resistant to treatment have shown a high response rate to a potent new immunotherapy drug, in a Peter Mac-led clinical trial.

Oncology & Cancer

Study unveils the role of gamma-delta T cells in cancer immunology

A new study published in Cell Reports Medicine reveals critical insights into the role of gamma-delta T cells across 33 cancer types, shedding light on their potential as clinical biomarkers and therapeutic targets in cancer ...

Oncology & Cancer

Colonoscopies among the young are on the rise

Colon cancers are increasing among younger Americans, so much so that experts advised in 2021 that colonoscopy screening begins at the age of 45, not 50 as had been previously recommended.

Oncology & Cancer

New imaging technique accurately detects aggressive kidney cancer

A new study led by investigators from the UCLA Health Jonsson Comprehensive Cancer Center has demonstrated a new, non-invasive imaging technique can accurately detect clear-cell renal cell carcinoma, the most common form ...

Oncology & Cancer

Enhanced tumor modeling using Laponite bioinks for 3D bioprinting

Scientists from the Terasaki Institute for Biomedical Innovation (TIBI) have developed a nanoengineered bioink with improved bonding and cross-linking capabilities for 3D bioprinting of tumor models. A key component of this ...

Oncology & Cancer

Tackling an aggressive, treatment-resistant lymphoma

Anaplastic large cell lymphoma, a form of non-Hodgkin lymphoma, is the most common aggressive lymphoma in children. Chemotherapy and radiation fail to cure about 30% of cases. When tumors are driven by the oncogene ALK—which ...

Oncology & Cancer

New insights into how RNA modification promotes pancreatic cancer

Chemical modifications of RNA molecules, such as m6A, can critically impact gene expression, influencing various aspects of cancer development and progression. However, while studies into m6A modification of messenger RNA ...

Oncology & Cancer

A novel strategy to suppress triple negative breast cancer growth

In 2022, a team of researchers at Baylor College of Medicine discovered that a little-known enzyme called MAPK4 is involved in the growth of triple negative breast cancer (TNBC) and its resistance to certain therapies. Looking ...

Oncology & Cancer

Consumer health: Reducing your risk of lung cancer

Lung cancer is the leading cause of cancer deaths in the U.S., accounting for about 1 in 5 of all cancer deaths, according to the American Cancer Society. Lung cancer claims more lives each year than colon, breast and prostate ...